<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>ar710</ui>
   <ji>ARJ</ji>
   <fm>
      <dochead>Meeting abstract</dochead>
      <bibl>
         <title>
            <p>A novel juvenile idiopathic arthritis (JIA) susceptibility gene in HLA class I region marked by microsatellite D6S265</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Smerdel</snm>
               <fnm>A</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Lie</snm>
               <fnm>BA</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Finholt</snm>
               <fnm>C</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Ploski</snm>
               <fnm>R</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A5">
               <snm>F&#248;rre</snm>
               <fnm>&#216;</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A6">
               <snm>Undlien</snm>
               <fnm>DE</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A7">
               <snm>Thorsby</snm>
               <fnm>E</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>nstitute of Immunology, Department of Rheumatology, Rikshospitalet University Hospital, Oslo, Norway</p>
            </ins>
         </insg>
         <source>Arthritis Res Ther</source>
         <supplement>
            <title>
               <p>23rd European Workshop for Rheumatology Research</p>
            </title>
            <sponsor>
               <note>The organizer would like to thank the following companies who have generously supported the 23rd European Workshop for Rheumatology Research: Abbott, Amgen, Aventis, Merck Sharp and Dohme, Novartis, Pharmacia, Schering-Plough, Wyeth</note>
            </sponsor>
            <note>Meeting abstracts</note>
         </supplement>
         <conference>
            <title>
               <p>23rd European Workshop for Rheumatology Research</p>
            </title>
            <location>Marseille, France</location>
            <date-range>27 February &#8211; 2 March 2003</date-range>
         </conference>
         <issn>1478-6354</issn>
         <pubdate>2003</pubdate>
         <volume>5</volume>
         <issue>Suppl 1</issue>
         <fpage>80</fpage>
         <xrefbib>
            <pubid idtype="doi">10.1186/ar710</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>24</day>
               <month>2</month>
               <year>2003</year>
            </date>
         </pub>
      </history>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Objective</p>
         </st>
         <p>Juvenile idiopathic arthritis (JIA), a chronic inflammatory joint disease, is associated with particular alleles at three different HLA loci: HLA-A, DR-DQ, and DP. We have recently found that a gene in the vicinity of microsatellite (MS) marker D6S265 in the HLA class I region may contribute to a predisposition to JIA. To further evaluate the implicated region containing marker D6S265, we analyzed a denser set of polymorphic markers covering ~1.8 Mb of the HLA region around D6S265.</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>We investigated 102 patients with JIA classified according to the ACR criteria. As controls we selected 207 healthy, unrelated individuals. Only patients and controls carrying the DR8-DQ4 haplo-type were included in this study. We used 13 MS markers covering a region ~1 Mb and ~0.8 Mb centromeric and telomeric, respectively, to D6S265. An EM- algorithm was used to estimate haplotypes, and the distribution of MS alleles on the DR8-DQ4 haplotype was compared between patients and controls, in order to exclude associations secondary to linkage disequilibrium (LD) with this high-risk haplotype.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>The strongest association with JIA was observed for allele 5 at D6S265 (OR = 3.1; <it>P</it><sub>c</sub> &lt; 10<sup>-4</sup>) (~100 kb centromeric to HLA-A). LD and haplotype analyses showed that the D6S265*5 association was not secondary to an association to HLA-A*0201, previously reported to be associated with JIA. Positive associations with JIA showed also: allele 7 at D6S2704 (<it>P</it><sub>c</sub> &lt; 0.05) (~160 kb centromeric to D6S265) and allele 11 at D6S2707 (<it>P</it><sub>c</sub> &lt; 0.005) (~300 kb telomeric to D6S265). This strongly suggests that our initially observed association to D6S265*5 is not a false positive result, but reflects the presence of a true disease-susceptibility gene in this region. Furthermore, the analysis of three-marker rolling haplotypes demonstrated a peak of association close to D6S265.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>This hitherto unidentified gene in the HLA class I region, marked by D6S265*5 and distinct from HLA-A2, influences the risk for JIA conferred by the DR8-DQ4 haplotype. The gene in question remains to be identified.</p>
      </sec>
   </bdy>
</art>

